Afyren secures over 60 million euros of financing to move into its industrial development phase

Wall Street, New York City

French Industrial biotech company Afyren, which produces high-value bio-based building blocks to manufacture acids using fermentation technologies, has completed a 21 million euro round of fundraising, led by Sofinnova Partners and Valquest Partners, bringing on board Supernova, Crédit Agricole Création and Crédit Agricole Centre France alongside its historical shareholders AFY Partners and Sofimac Régions (Sofimac and the Jérémie Innovation 1 and 2 funds).

Continue reading